Advertisement

Topics

"A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock" Drugs and Medication Database

20:27 EDT 25th March 2019 | BioPortfolio

Here are the most relevant "A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock" Drugs and Medications that we have found in our database.

More Information about "A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock" on BioPortfolio

We have published hundreds of A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock news stories on BioPortfolio along with dozens of A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock Clinical Trials and PubMed Articles about A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock Companies in our database. You can also find out about relevant A Study To Compare The Efficacy And Safety Of 2 Dosing Regimens Of IV Infusions Of AZD9773 (CytoFab™) With Placebo In Adult Patients With Severe Sepsis And/or Septic Shock Drugs and Medications on this site too.

Showing "Study Compare Efficacy Safety Dosing Regimens Infusions AZD9773" Drugs and Medications, all 12

Probably Relevant

Antiseptic skin cleanser [cardinal health]

Drug Facts

Possibly Relevant

Vectibix [amgen inc]

These highlights do not include all the information needed to use VECTIBIX safely and effectively. See full prescribing information for VECTIBIX .     VECTIBIX   (panitumumab)   I njection for intravenous use Initial U.S. Approval: 200 6

Arzerra [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use ARZERRA safely and effectively. See full prescribing information for ARZERRA. ARZERRA (ofatumumab) injection, for intravenous useInitial U.S. Approval: 2009

Norepinephrine bitartrate [mylan institutional llc]

Norepinephrine Bitartrate Injection, USP

Calcium chloride [american regent, inc.]

CALCIUM CHLORIDE INJECTION, USP 10%

Potassium phosphates [fresenius kabi usa, llc]

Potassium Phosphates Injection USP

Rifampin [west-ward pharmaceuticals corp]

RIFAMPIN FOR INJECTION, USP

Rifampin [akorn, inc.]

RIFAMPIN FOR INJECTION USP

Rifampin [heritage pharmaceuticals inc.]

RIFAMPIN FOR INJECTION, USP

Zosyn [wyeth pharmaceuticals inc., a subsidiary of pfizer inc.]

ZOSYN (Piperacillin and Tazobactam for Injection, USP)

Zosyn [wyeth piperacillin division of wyeth holdings corporation, a subsidiary of pfizer]

ZOSYN (Piperacillin and Tazobactam for Injection, USP)

Darzalex [janssen biotech, inc.]

These highlights do not include all the information needed to use DARZALEXsafely and effectively. See full prescribing information for DARZALEX. DARZALEX (daratumumab) injection, for intravenous use Initial U.S. Approval – 2015



Advertisement
Quick Search
Advertisement
Advertisement